Transforming Product & Portfolio Management Through Responsible, Human-Centric AI

A global medical technology company with a broad portfolio of medical devices, instrument platforms, and reagents faced growing operational strain within its development organization. While teams across engineering, regulatory, finance, and operations demonstrated strong technical capability and collaboration, core development workflows remained manual and fragmented. These inefficiencies consumed scarce resources, increased compliance risk, and slowed product timelines—limiting the organization’s ability to scale innovation in a highly regulated environment. Recognizing that its expansive digital footprint represented an opportunity, leadership identified that AI could reduce operational friction, strengthen cross-functional execution, and refocus teams on high-value work. The company partnered with Syner-G’s Strategy and Transformation team to launch a targeted AI transformation to strengthen its R&D innovation portfolio and enable more efficient, scalable execution.

Using its 3D Intelligence (3Di™) methodology, Syner-G partnered with the PMO, Finance, and Product teams to transform critical development workflows by combining digital capability design and AI technologies with intentional workforce engagement. Teams were engaged as co-creators — shaping futurestate processes and redefining their roles within AI-augmented workflows.

The result: AI-designed ways of working centered on people, not technology.

The 3Di™ approach enabled the organization to move from AI experimentation to operational impact, delivering measurable productivity gains, accelerating cycle times, improving user adoption, and building scalable capabilities for future AI-enabled ways of working.